Never Waste a Good Crisis: Confronting Reproducibility in Translational Research

Cell Metabolism

Volumn 24, Issue 3, 2016, Pages 348-360

  Drucker, Daniel J ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BLACK CURRANT EXTRACT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EXENDIN 4; GASTROINTESTINAL HORMONE; GLUCOSE; INCRETIN; NATURAL PRODUCT; OLEIC ACID; PECTIN;

APPLE; BASIC RESEARCH; BLACK CURRANT; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DYSBIOSIS; EDITOR; ENTEROENDOCRINE CELL; GLUCONEOGENESIS; HISTOLOGY; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; METABOLIC DISORDER; METABOLISM; MOLECULAR BIOLOGY; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PHENOTYPE; PRECLINICAL STUDY; PRIORITY JOURNAL; PROBLEM BEHAVIOR; PUBLIC RELATIONS; REPRODUCIBILITY; SCIENCE; SCIENTIST; STATISTICAL ANALYSIS; TRANSLATIONAL RESEARCH; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; INTERPERSONAL COMMUNICATION; MEDICAL RESEARCH; MOUSE; PUBLISHING; RESEARCH;

ANIMAL EXPERIMENTATION; ANIMALS; BIOMEDICAL RESEARCH; COMMUNICATION; MICE; MODELS, ANIMAL; PUBLISHING; REPRODUCIBILITY OF RESULTS; RESEARCH REPORT; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84990833589     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2016.08.006     Document Type: Note

References (75)

1. Arda, H.E., Li, L., Tsai, J., Torre, E.A., Rosli, Y., Peiris, H., Spitale, R.C., Dai, C., Gu, X., Qu, K., et al. Age-Dependent Pancreatic Gene Regulation Reveals Mechanisms Governing Human β Cell Function. Cell Metab. 23 (2016), 909–920.
2. Ayala, J.E., Bracy, D.P., James, F.D., Burmeister, M.A., Wasserman, D.H., Drucker, D.J., Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance. Endocrinology 151 (2010), 4678–4687.
3. Baker, M., Reproducibility crisis: Blame it on the antibodies. Nature 521 (2015), 274–276.
4. Baker, D., Lidster, K., Sottomayor, A., Amor, S., Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies. PLoS Biol., 12, 2014, e1001756.
5. Battaglia, M., Atkinson, M.A., The streetlight effect in type 1 diabetes. Diabetes 64 (2015), 1081–1090.
6. Begley, C.G., Ellis, L.M., Drug development: Raise standards for preclinical cancer research. Nature 483 (2012), 531–533.
7. Begley, C.G., Ioannidis, J.P., Reproducibility in science: improving the standard for basic and preclinical research. Circ. Res. 116 (2015), 116–126.
8. Bersell, K., Choudhury, S., Mollova, M., Polizzotti, B.D., Ganapathy, B., Walsh, S., Wadugu, B., Arab, S., Kühn, B., Moderate and high amounts of tamoxifen in αMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death. Dis. Model. Mech. 6 (2013), 1459–1469.
9. Beura, L.K., Hamilton, S.E., Bi, K., Schenkel, J.M., Odumade, O.A., Casey, K.A., Thompson, E.A., Fraser, K.A., Rosato, P.C., Filali-Mouhim, A., et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532 (2016), 512–516.
10. Bonner-Weir, S., In't Veld, P.A., Weir, G.C., Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies. Diabetes Obes. Metab. 16 (2014), 661–666.
11. Bradbury, A., Plückthun, A., Reproducibility: Standardize antibodies used in research. Nature 518 (2015), 27–29.
12. Brouwers, B., de Faudeur, G., Osipovich, A.B., Goyvaerts, L., Lemaire, K., Boesmans, L., Cauwelier, E.J., Granvik, M., Pruniau, V.P., Van Lommel, L., et al. Impaired islet function in commonly used transgenic mouse lines due to human growth hormone minigene expression. Cell Metab. 20 (2014), 979–990.
13. Campbell, J.E., Drucker, D.J., Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab. 17 (2013), 819–837.
14. Claus, S.P., Tsang, T.M., Wang, Y., Cloarec, O., Skordi, E., Martin, F.P., Rezzi, S., Ross, A., Kochhar, S., Holmes, E., Nicholson, J.K., Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol. Syst. Biol., 4, 2008, 219.
15. Clayton, J.A., Collins, F.S., Policy: NIH to balance sex in cell and animal studies. Nature 509 (2014), 282–283.
16. Collins, F.S., Tabak, L.A., Policy: NIH plans to enhance reproducibility. Nature 505 (2014), 612–613.
17. Donath, M.Y., Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat. Rev. Drug Discov. 13 (2014), 465–476.
18. Donath, M.Y., Multiple benefits of targeting inflammation in the treatment of type 2 diabetes. Diabetologia 59 (2016), 679–682.
19. Drucker, D.J., Incretin-based therapy and the quest for sustained improvements in β-cell health. Diabetes Care 34 (2011), 2133–2135.
20. Drucker, D.J., Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls. Diabetes 62 (2013), 3316–3323.
21. Drucker, D.J., Deciphering metabolic messages from the gut drives therapeutic innovation: the 2014 Banting Lecture. Diabetes 64 (2015), 317–326.
22. Drucker, D.J., Evolving Concepts and Translational Relevance of Enteroendocrine Cell Biology. J. Clin. Endocrinol. Metab. 101 (2016), 778–786.
23. Drucker, D.J., Yusta, B., Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annu. Rev. Physiol. 76 (2014), 561–583.
24. Egan, A.G., Blind, E., Dunder, K., de Graeff, P.A., Hummer, B.T., Bourcier, T., Rosebraugh, C., Pancreatic safety of incretin-based drugs–FDA and EMA assessment. N. Engl. J. Med. 370 (2014), 794–797.
25. Emambokus, N., Granger, A., The Elephant in the Room. Cell Metab., 22, 2015, 345.
26. Freedman, L.P., Gibson, M.C., Ethier, S.P., Soule, H.R., Neve, R.M., Reid, Y.A., Reproducibility: changing the policies and culture of cell line authentication. Nat. Methods 12 (2015), 493–497.
27. Freedman, L.P., Gibson, M.C., Bradbury, A.R.M., Buchberg, A.M., Davis, D., Dolled-Filhart, M.P., Lund-Johansen, F., Rimm, D.L., [Letter to the Editor] The need for improved education and training in research antibody usage and validation practices. Biotechniques 61 (2016), 16–18.
28. Fuchsberger, C., Flannick, J., Teslovich, T.M., Mahajan, A., Agarwala, V., Gaulton, K.J., Ma, C., Fontanillas, P., Moutsianas, L., McCarthy, D.J., et al. The genetic architecture of type 2 diabetes. Nature 536 (2016), 41–47.
29. Goodman, S.N., Fanelli, D., Ioannidis, J.P., What does research reproducibility mean?. Sci. Transl. Med., 8, 2016, 341ps12.
30. Gore, A.C., Editorial: antibody validation requirements for articles published in endocrinology. Endocrinology 154 (2013), 579–580.
31. Hadjiyanni, I., Baggio, L.L., Poussier, P., Drucker, D.J., Exendin-4 modulates diabetes onset in nonobese diabetic mice. Endocrinology 149 (2008), 1338–1349.
32. Hansotia, T., Maida, A., Flock, G., Yamada, Y., Tsukiyama, K., Seino, Y., Drucker, D.J., Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure. J. Clin. Invest. 117 (2007), 143–152.
33. Harwood, H.J. Jr., Listrani, P., Wagner, J.D., Nonhuman primates and other animal models in diabetes research. J. Diabetes Sci. Technol. 6 (2012), 503–514.
34. Heffner, C.S., Herbert Pratt, C., Babiuk, R.P., Sharma, Y., Rockwood, S.F., Donahue, L.R., Eppig, J.T., Murray, S.A., Supporting conditional mouse mutagenesis with a comprehensive cre characterization resource. Nat. Commun., 3, 2012, 1218.
35. Hodge, R.J., Paulik, M.A., Walker, A., Boucheron, J.A., McMullen, S.L., Gillmor, D.S., Nunez, D.J., Weight and Glucose Reduction Observed with a Combination of Nutritional Agents in Rodent Models Does Not Translate to Humans in a Randomized Clinical Trial with Healthy Volunteers and Subjects with Type 2 Diabetes. PLoS ONE, 11, 2016, e0153151.
36. Hrabě de Angelis, M., Nicholson, G., Selloum, M., White, J.K., Morgan, H., Ramirez-Solis, R., Sorg, T., Wells, S., Fuchs, H., Fray, M., et al., EUMODIC Consortium. Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics. Nat. Genet. 47 (2015), 969–978.
37. Huh, W.J., Khurana, S.S., Geahlen, J.H., Kohli, K., Waller, R.A., Mills, J.C., Tamoxifen induces rapid, reversible atrophy, and metaplasia in mouse stomach. Gastroenterology 142 (2012), 21–24.e7.
38. Kayton, N.S., Poffenberger, G., Henske, J., Dai, C., Thompson, C., Aramandla, R., Shostak, A., Nicholson, W., Brissova, M., Bush, W.S., Powers, A.C., Human islet preparations distributed for research exhibit a variety of insulin-secretory profiles. Am. J. Physiol. Endocrinol. Metab. 308 (2015), E592–E602.
39. Kilkenny, C., Parsons, N., Kadyszewski, E., Festing, M.F., Cuthill, I.C., Fry, D., Hutton, J., Altman, D.G., Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLoS ONE, 4, 2009, e7824.
40. Kilkenny, C., Browne, W.J., Cuthill, I.C., Emerson, M., Altman, D.G., Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol., 8, 2010, e1000412.
41. Koitabashi, N., Bedja, D., Zaiman, A.L., Pinto, Y.M., Zhang, M., Gabrielson, K.L., Takimoto, E., Kass, D.A., Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models. Circ. Res. 105 (2009), 12–15.
42. Landis, S.C., Amara, S.G., Asadullah, K., Austin, C.P., Blumenstein, R., Bradley, E.W., Crystal, R.G., Darnell, R.B., Ferrante, R.J., Fillit, H., et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490 (2012), 187–191.
43. Lee, J.Y., Ristow, M., Lin, X., White, M.F., Magnuson, M.A., Hennighausen, L., RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function. J. Biol. Chem. 281 (2006), 2649–2653.
44. Libby, P., Murine “model” monotheism: an iconoclast at the altar of mouse. Circ. Res. 117 (2015), 921–925.
45. Lim, G.E., Brubaker, P.L., Glucagon-Like Peptide 1 Secretion by the L-Cell: The View From Within. Diabetes 55 (2006), S70–S77.
46. Lyon, J., Manning Fox, J.E., Spigelman, A.F., Kim, R., Smith, N., O'Gorman, D., Kin, T., Shapiro, A.M., Rajotte, R.V., MacDonald, P.E., Research-Focused Isolation of Human Islets From Donors With and Without Diabetes at the Alberta Diabetes Institute IsletCore. Endocrinology 157 (2016), 560–569.
47. Macleod, M.R., Lawson McLean, A., Kyriakopoulou, A., Serghiou, S., de Wilde, A., Sherratt, N., Hirst, T., Hemblade, R., Bahor, Z., Nunes-Fonseca, C., et al. Risk of Bias in Reports of In Vivo Research: A Focus for Improvement. PLoS Biol., 13, 2015, e1002273.
48. Magnuson, M.A., Osipovich, A.B., Pancreas-specific Cre driver lines and considerations for their prudent use. Cell Metab. 18 (2013), 9–20.
49. Mancini, A.D., Poitout, V., GPR40 agonists for the treatment of type 2 diabetes: life after ‘TAKing’ a hit. Diabetes Obes. Metab. 17 (2015), 622–629.
50. McNutt, M., Journals unite for reproducibility. Science, 346, 2014, 679.
51. Mekada, K., Abe, K., Murakami, A., Nakamura, S., Nakata, H., Moriwaki, K., Obata, Y., Yoshiki, A., Genetic differences among C57BL/6 substrains. Exp. Anim. 58 (2009), 141–149.
52. Moullan, N., Mouchiroud, L., Wang, X., Ryu, D., Williams, E.G., Mottis, A., Jovaisaite, V., Frochaux, M.V., Quiros, P.M., Deplancke, B., et al. Tetracyclines Disturb Mitochondrial Function across Eukaryotic Models: A Call for Caution in Biomedical Research. Cell Rep., 2015 S2211-1247(15)00180-1.
53. Pais, R., Gribble, F.M., Reimann, F., Stimulation of incretin secreting cells. Ther. Adv. Endocrinol. Metab. 7 (2016), 24–42.
54. Panjwani, N., Mulvihill, E.E., Longuet, C., Yusta, B., Campbell, J.E., Brown, T.J., Streutker, C., Holland, D., Cao, X., Baggio, L.L., Drucker, D.J., GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice. Endocrinology 154 (2013), 127–139.
55. Parnaud, G., Bosco, D., Berney, T., Pattou, F., Kerr-Conte, J., Donath, M.Y., Bruun, C., Mandrup-Poulsen, T., Billestrup, N., Halban, P.A., Proliferation of sorted human and rat beta cells. Diabetologia 51 (2008), 91–100.
56. Prinz, F., Schlange, T., Asadullah, K., Believe it or not: how much can we rely on published data on potential drug targets?. Nat. Rev. Drug Discov., 10, 2011, 712.
57. Pyke, C., Knudsen, L.B., The glucagon-like peptide-1 receptor–or not?. Endocrinology 154 (2013), 4–8.
58. Pyke, C., Heller, R.S., Kirk, R.K., Ørskov, C., Reedtz-Runge, S., Kaastrup, P., Hvelplund, A., Bardram, L., Calatayud, D., Knudsen, L.B., GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. Endocrinology 155 (2014), 1280–1290.
59. Rankin, M.M., Kushner, J.A., Adaptive beta-cell proliferation is severely restricted with advanced age. Diabetes 58 (2009), 1365–1372.
60. Ritter, K., Buning, C., Halland, N., Pöverlein, C., Schwink, L., G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges. J. Med. Chem. 59 (2016), 3579–3592.
61. Rother, K.I., Spain, L.M., Wesley, R.A., Digon, B.J. 3rd, Baron, A., Chen, K., Nelson, P., Dosch, H.M., Palmer, J.P., Brooks-Worrell, B., et al. Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes. Diabetes Care 32 (2009), 2251–2257.
62. Schmidt-Supprian, M., Rajewsky, K., Vagaries of conditional gene targeting. Nat. Immunol. 8 (2007), 665–668.
63. Scrocchi, L.A., Drucker, D.J., Effects of aging and a high fat diet on body weight and glucose control in glucagon-like peptide-1 receptor -/- mice. Endocrinology 139 (1998), 3127–3132.
64. Sigmund, C.D., Viewpoint: are studies in genetically altered mice out of control?. Arterioscler. Thromb. Vasc. Biol. 20 (2000), 1425–1429.
65. Speakman, J.R., Keijer, J., Not so hot: Optimal housing temperatures for mice to mimic the thermal environment of humans. Mol. Metab. 2 (2012), 5–9.
66. Teufel, A., Itzel, T., Erhart, W., Brosch, M., Wang, X.Y., Kim, Y.O., von Schönfels, W., Herrmann, A., Brückner, S., Stickel, F., et al. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients. Gastroenterology, 2016, 10.1053/j.gastro.2016.05.051 S0016-5085(16)34622-4.
67. Tian, X.Y., Ganeshan, K., Hong, C., Nguyen, K.D., Qiu, Y., Kim, J., Tangirala, R.K., Tontonoz, P., Chawla, A., Thermoneutral Housing Accelerates Metabolic Inflammation to Potentiate Atherosclerosis but Not Insulin Resistance. Cell Metab. 23 (2016), 165–178.
68. Tschen, S.I., Dhawan, S., Gurlo, T., Bhushan, A., Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes 58 (2009), 1312–1320.
69. Ussar, S., Griffin, N.W., Bezy, O., Fujisaka, S., Vienberg, S., Softic, S., Deng, L., Bry, L., Gordon, J.I., Kahn, C.R., Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome. Cell Metab. 22 (2015), 516–530.
70. Vasandani, C., Clark, G., Adams-Huet, B., Quittner, C., and Garg, A. (2016). Efficacy of Metreleptin in Patients with Type 1 Diabetes. In 2016 Annual Meeting of the American Diabetes Association (New Orleans).
71. Vasilevsky, N.A., Brush, M.H., Paddock, H., Ponting, L., Tripathy, S.J., Larocca, G.M., Haendel, M.A., On the reproducibility of science: unique identification of research resources in the biomedical literature. PeerJ, 1, 2013, e148.
72. Wang, B., Chandrasekera, P.C., Pippin, J.J., Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr. Diabetes Rev. 10 (2014), 131–145.
73. Wicksteed, B., Brissova, M., Yan, W., Opland, D.M., Plank, J.L., Reinert, R.B., Dickson, L.M., Tamarina, N.A., Philipson, L.H., Shostak, A., et al. Conditional gene targeting in mouse pancreatic ß-Cells: analysis of ectopic Cre transgene expression in the brain. Diabetes 59 (2010), 3090–3098.
74. Woods, S.C., Begg, D.P., Food for Thought: Revisiting the Complexity of Food Intake. Cell Metab. 22 (2015), 348–351.
75. Ye, R., Wang, Q.A., Tao, C., Vishvanath, L., Shao, M., McDonald, J.G., Gupta, R.K., Scherer, P.E., Impact of tamoxifen on adipocyte lineage tracing: Inducer of adipogenesis and prolonged nuclear translocation of Cre recombinase. Mol. Metab. 4 (2015), 771–778.